Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

Lymphodepletion chemotherapy with CD19-targeted chimeric antigen receptor–modified T (CAR-T)-cell immunotherapy is a novel treatment for refractory or relapsed B-cell malignancies. Infectious complications of this approach have not been systematically studied. We evaluated infections occurring betwe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Hill, Joshua A., Li, Daniel, Hay, Kevin A., Green, Margaret L., Cherian, Sindhu, Chen, Xueyan, Riddell, Stanley R., Maloney, David G., Boeckh, Michael, Turtle, Cameron J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Immunobiology and Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5755046/
https://ncbi.nlm.nih.gov/pubmed/29038338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-793760
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados